https://en.sputniknews.africa/20261113/1090918023.html

Russian Pharmaceutical Company Opens Division in China to Focus on Joint Research, CEO Says

Russian Pharmaceutical Company Opens Division in China to Focus on Joint Research, CEO Says

Sputnik Africa

Russian Pharmaceutical Company Opens Division in China to Focus on Joint Research, CEO SaysThe new division of Promomed—one of Russia's leading innovative... 13.11.2026, Sputnik Africa

2026-11-13T17:19+0100

2026-11-13T17:19+0100

2026-11-13T17:24+0100

sputnik africa

https://cdn1.img.sputniknews.africa/img/07ea/0b/0d/1090917864_0:0:1280:720_1920x0_80_0_0_4dc2c49e4063fcb5591ce143e8c7931f.jpg

Russian Pharmaceutical Company Opens Division in China to Focus on Joint Research, CEO SaysThe new division of Promomed—one of Russia's leading innovative biopharmaceutical companies that implements a full-cycle production model—is going to focus on joint research, molecule development, and clinical trials, Petr Bely told Sputnik."Russia has always been a source of intellectual solutions," Bely emphasized, adding that Moscow and Beijing have excellent opportunities in exchanging medicines. Promomed's drugs are of interest to Chinese colleagues, while Chinese drugs will be presented in Russia based on research, he noted. ℹ Earlier, Bely said that Russia and Promomed are ready to supply Africa with medicines, calling export opportunities "quite interesting." Watch the video to learn more about Russia-China cooperation.Subscribe to @sputnik_africa Sputnik Africa | X

2026

News

en_EN

sputnik africa